AC Immune SA

NASDAQ:ACIU

3.11 (USD) • At close October 22, 2024
Bedrijfsnaam AC Immune SA
Symbool ACIU
Munteenheid USD
Prijs 3.11
Beurswaarde 310,006,044
Dividendpercentage 0%
52-weken bereik 2.25 - 5.14
Industrie Biotechnology
Sector Healthcare
CEO Dr. Andrea Pfeifer Ph.D.
Website https://www.acimmune.com

An error occurred while fetching data.

Over AC Immune SA

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are

Vergelijkbare Aandelen

Precigen, Inc. logo

Precigen, Inc.

PGEN

0.937 USD

ESSA Pharma Inc. logo

ESSA Pharma Inc.

EPIX

5.74 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

TNYA

1.91 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.08 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

33.39 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)